Related Experiment Video
Updated: Mar 16, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Pediatric thromboembolism: a national survey in Japan
Akira Ishiguro1,2, Chibueze Chioma Ezinne3, Nobuaki Michihata4
1Division of Hematology, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan. ishiguro-a@ncchd.go.jp.
Insights
Pediatric thromboembolism is rising. Congenital thrombophilia, including protein C, S, and antithrombin defects, was identified in 19.3% of Japanese children, leading to earlier onset and more frequent recurrence.
Area of Science:
- Pediatric Hematology
- Thrombophilia Research
- Epidemiology
Background:
- Thromboembolism (blood clots) is increasingly diagnosed in children.
- The prevalence of pediatric thrombophilia varies globally and was previously unquantified in Japan.
Purpose of the Study:
- To investigate the incidence and characteristics of symptomatic thromboembolism in Japanese children.
- To identify the prevalence of congenital thrombophilia and associated risk factors in this population.
Main Methods:
- A nationwide survey was conducted among pediatric departments and specialists in Japan.
- Data were collected on pediatric patients diagnosed with symptomatic thromboembolism between 2006 and 2010.
- Eligible cases were analyzed for congenital and non-congenital causes of thrombophilia.
Main Results:
- Congenital thrombophilia was identified in 19.3% of cases (n=54), primarily involving defects in protein C, protein S, and antithrombin.
- Unlike in Caucasians, mutations in factor V Leiden and prothrombin G20210A were absent.
- Children with congenital thrombophilia experienced earlier thromboembolism onset, higher consanguinity rates, and increased recurrence and post-thrombotic syndromes.
- Non-congenital causes included congenital heart disease, central venous catheters, nephrotic syndrome, antiphospholipid syndrome, and malignancy.
Conclusions:
- This study presents the first comprehensive data on pediatric thromboembolism and thrombophilia in Japan.
- Congenital thrombophilia significantly impacts disease presentation, recurrence, and long-term outcomes in children.
- Optimized management strategies are crucial given the high rates of recurrence and sequelae.
Abstract:
Thromboembolism is being detected at increasing rates in pediatric tertiary care hospitals. The incidence of pediatric thrombophilia differs across countries, and is unknown in Japan. We sent a survey to 520 pediatric department heads and 629 specialists, requesting details on patients who developed symptomatic thromboembolism between 2006 and 2010. Of 280 eligible cases, congenital thrombophilia and other conditions were reported. Congenital thrombophilia (n = 54, 19.3 %) comprised defects in protein C (27), protein S (9), and antithrombin (7). None had mutations in factor V Leiden or prothrombin G20210A, both of which are frequent in Caucasians. Non-congenital causes of thrombophilia included congenital heart disease, the use of central venous catheters, nephrotic syndrome, antiphospholipid syndrome, and malignancy with or without use of L-asparaginase. Patients with congenital thrombophilia developed thromboembolism at a significantly younger age (median 1.0 vs. 5.0 years, p = 0.014), had a higher frequency of consanguinity (35.2 vs. 1.8 %, p < 0.001) and post-thrombotic syndromes (29.6 vs. 13.3 %, p = 0.007) than those who did not. Thromboembolism in children with congenital thrombophilia recurred more frequently (50.0 vs. 13.7 %, p < 0.001) and was associated with more sequelae (61.1 vs. 37.2 %, p = 0.009) than in children without congenital thrombophilia. This nationwide survey provides the first comprehensive study of Japanese children with symptomatic thromboembolism. Significant recurrence and sequelae require optimized standards.
More Related Videos
09:37Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
06:22Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children
Published on: February 10, 2023
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pulmonary Embolism I: Introduction
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism